| Nanocarrier vaccines for SARS-CoV-2 J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Advanced Drug Delivery Reviews 171, 215-239, 2021 | 94 | 2021 |
| CD4+ effector T cells accelerate Alzheimer’s disease in mice J Machhi, P Yeapuri, Y Lu, E Foster, R Chikhale, J Herskovitz, ... Journal of neuroinflammation 18, 1-23, 2021 | 63 | 2021 |
| A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Journal of Neuroimmune Pharmacology 16, 270-288, 2021 | 45 | 2021 |
| Defining the innate immune responses for SARS-CoV-2-human macrophage interactions MM Abdelmoaty, P Yeapuri, J Machhi, KE Olson, F Shahjin, V Kumar, ... Frontiers in immunology 12, 741502, 2021 | 42 | 2021 |
| Europium-doped cerium oxide nanoparticles for microglial amyloid beta clearance and homeostasis J Machhi, P Yeapuri, M Markovic, M Patel, W Yan, Y Lu, JD Cohen, ... ACS chemical neuroscience 13 (8), 1232-1244, 2022 | 17 | 2022 |
| Encapsulation of an EP67-conjugated CTL peptide vaccine in nanoscale biodegradable particles increases the efficacy of respiratory immunization and affects the magnitude and … BVK Karuturi, SB Tallapaka, P Yeapuri, SM Curran, SD Sanderson, ... Molecular pharmaceutics 14 (5), 1469-1481, 2017 | 15 | 2017 |
| Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease MM Abdelmoaty, J Machhi, P Yeapuri, F Shahjin, V Kumar, KE Olson, ... Clinical and Translational Medicine 12 (7), e958, 2022 | 13 | 2022 |
| Development of an extended half-life GM-CSF fusion protein for Parkinson's disease P Yeapuri, KE Olson, Y Lu, MM Abdelmoaty, KL Namminga, M Markovic, ... Journal of Controlled Release 348, 951-965, 2022 | 12 | 2022 |
| Multipolymer microsphere delivery of SARS-CoV-2 antigens F Shahjin, M Patel, J Machhi, JD Cohen, MU Nayan, P Yeapuri, C Zhang, ... Acta Biomaterialia 158, 493-509, 2023 | 10 | 2023 |
| Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after … SB Tallapaka, BVK Karuturi, P Yeapuri, SM Curran, YA Sonawane, ... International journal of pharmaceutics 565, 242-257, 2019 | 10 | 2019 |
| Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice P Yeapuri, J Machhi, Y Lu, MM Abdelmoaty, R Kadry, M Patel, S Bhattarai, ... Molecular neurodegeneration 18 (1), 97, 2023 | 6 | 2023 |
| Prodrug therapies for infectious and neurodegenerative diseases M Markovic, S Deodhar, J Machhi, P Yeapuri, M Saleh, B J. Edagwa, ... Pharmaceutics 14 (3), 518, 2022 | 6 | 2022 |
| Protective effect of CP690550 in MPTP-induced Parkinson’s like behavioural, biochemical and histological alterations in mice A Alshammari, M Alharbi, NA Albekairi, TH Albekairi, OO Alharbi, ... Neurotoxicity Research 40 (2), 564-572, 2022 | 3 | 2022 |
| Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease M Markovic, P Yeapuri, KL Namminga, Y Lu, M Saleh, KE Olson, ... Neuroimmune Pharmacology and Therapeutics 1 (1), 43-50, 2022 | 3 | 2022 |
| Immune senescence in aged APP/PS1 mice MM Abdelmoaty, P Yeapuri, J Machhi, Y Lu, KL Namminga, R Kadry, E Lu, ... NeuroImmune Pharmacology and Therapeutics 2 (3), 317-330, 2023 | 1 | 2023 |
| CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities HE Gendelman, M Patel, S Panja, LA Zaman, P Yeapuri, S Bhattarai, ... | | 2024 |
| J. Edagwa, B.; Mosley, RL; Gendelman, HE Prodrug Therapies for Infectious and Neurodegenerative Diseases. Pharmaceutics 2022, 14, 518 M Markovic, S Deodhar, J Machhi, P Yeapuri, M Saleh s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Modulation of Immune Homeostasis in Neurodegenerative Diseases P Yeapuri | | 2022 |
| CD4+ T cell effector activities accelerate Alzheimer’s disease pathologies J Machhi, P Yeapuri, Y Lu, R Lee Mosley, HE Gendelman Alzheimer's & Dementia 17, e052738, 2021 | | 2021 |
| Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions (preprint) M Mostafa, P Yeapuri, J Machhi, K Olson, F Shahjin, Y Zhou, L Jingjing, ... | | 2021 |
